Form 8-K Annual Meeting Vote Results - 2015


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM 8-K
 
 
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
 
 
Date of report (Date of earliest event reported): May 28, 2015 (May 26, 2015)
 
 
MERCK & CO., INC.
(Exact name of registrant as specified in its charter)
 
 
 
 
 
 
New Jersey
 
1-6571
 
22-1918501
(State or other jurisdiction of
incorporation)
 
(Commission
File Number)
 
(IRS Employer
Identification No.)
 
 
2000 Galloping Hill Road, Kenilworth, NJ
 
07033
(Address of principal executive offices)
 
(Zip code)
Registrant’s telephone number, including area code: (908) 740-4000

 
N/A

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))






Item 5.07.
Submission of Matters to a Vote of Security Holders.
The following matters were voted upon at the Annual Meeting of Shareholders held on May 26, 2015, and received the votes set forth below:

1.
All of the following persons nominated were elected to serve as directors and received the number of votes set forth opposite their respective names:
 
Names
 
For
 
Against
 
Abstained
 
Broker
Non-Votes
Leslie A. Brun
 
2,026,434,326

 
49,511,061

 
5,509,078

 
353,592,519

Thomas R. Cech, Ph.D.
 
2,067,617,101

 
8,339,434

 
5,497,930

 
353,592,519

Kenneth C. Frazier
 
2,005,138,525

 
62,806,615

 
13,509,325

 
353,592,519

Thomas H. Glocer
 
2,055,980,668

 
19,834,481

 
5,639,316

 
353,592,519

William B. Harrison, Jr.
 
2,038,809,811

 
35,688,142

 
6,956,512

 
353,592,519

C. Robert Kidder
 
2,061,917,445

 
13,808,894

 
5,728,126

 
353,592,519

Rochelle B. Lazarus
 
2,060,643,174

 
15,309,274

 
5,502,017

 
353,592,519

Carlos E. Represas
 
2,055,253,112

 
20,564,497

 
5,636,856

 
353,592,519

Patricia F. Russo
 
1,989,502,407

 
85,468,289

 
6,483,769

 
353,592,519

Craig B. Thompson, M.D.
 
2,068,298,790

 
7,669,813

 
5,485,862

 
353,592,519

Wendell P. Weeks
 
2,062,043,756

 
13,787,369

 
5,623,340

 
353,592,519

Peter C. Wendell
 
2,052,749,778

 
23,161,934

 
5,542,753

 
353,592,519


2.
A proposal to approve, by a non-binding advisory vote, executive compensation of our Named Executive Officers received 1,982,456,004 votes FOR and 85,205,070 votes AGAINST, with 13,793,391 abstentions and 353,592,519 broker non-votes.

3.
A proposal to ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2015 received 2,406,727,002 votes FOR and 18,356,239 votes AGAINST, 9,963,743 abstentions.
        
4.
A proposal to amend and restate the Company's 2010 Incentive Stock Plan received 1,995,482,601 votes FOR and 72,665,769 votes AGAINST, with 13,306,095 abstentions and 353,592,519 broker non-votes.

5.
A proposal to amend and restate the Company's Executive Incentive Plan received 2,007,453,289 votes FOR and 60,079,877 votes AGAINST, with 13,921,299 abstentions and 353,592,519 broker non-votes.

6.
A shareholder proposal concerning shareholders’ right to act by written consent received 825,819,014 votes FOR and 1,242,161,815 votes AGAINST, with 13,473,636 abstentions and 353,592,519 broker non-votes.
              
7.
A shareholder proposal concerning accelerated vesting of equity awards received 509,716,218 votes FOR and 1,558,960,865 votes AGAINST, with 12,777,382 abstentions and 353,592,519 broker non-votes.
     






SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: May 28, 2015.
 
 
 
 
 
 
 
 
 
 
 
Merck & Co., Inc.
 
 
 
 
 
 
 
 
By:
 
/s/ Katie E. Fedosz
 
 
 
 
 
 
Name:    Katie E. Fedosz
 
 
 
 
 
 
Title:      Senior Assistant Secretary